Changes in lymphocyte subsets in children with newly diagnosed type 1 diabetes mellitus

被引:0
作者
Kadziela, K
Kowalska, H
Rymkiewicz-Kluczynska, B
Kowalska, M
Miszkurka, G
Rybczynska, J
Wasik, M
Pankowska, E
机构
[1] Med Univ Warsaw, Dept Paediat Endocrinol, PL-00576 Warsaw, Poland
[2] Med Univ Warsaw, Dept Lab Diagnost & Clin Immunol, PL-00576 Warsaw, Poland
[3] Med Univ Warsaw, Dept Paediat Diabetol & Metab Disorders, PL-00576 Warsaw, Poland
关键词
lymphocyte subpopulations; type 1 diabetes mellitus; children; antibodies; immunology;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to Assess changes in selected peripheral blood lymphocyte subsets in children and adolescents with newly diagnosed type 1 diabetes mellitus (DM) and determine the correlation between these changes and other immunological markers. The study involved a group of 39 patients aged 2-14 years and a control group. The number of T- and B-lymphocytes and the number of CD4, CD8, CD4/HLA-DR, CD8/HLA-DR, CD5/CD20 subsets were measured by flow-cytometry using monoclonal antibodies. Islet cell antibodies (ICA) and antibodies to glutamic acid decarboxylase (GADA) were assessed. In both the diabetic and control groups the number of T-and B-lymphocytes were within normal limits. In patients with DM, the percentage of CD5+/CD20+ cells was significantly increased compared with the control group (p <0.0001). ICA were positive in 80% of patients and GADA in nearly 65%. A positive correlation between the CD5/CD20 subset and ICA and GADA was found. In patients with a high percentage of CD5+/CD20+ lymphocytes, a higher percentage of activated subsets (CD4/HLA DR and CD8/HLA DR) was detected. In conclusion: CD5/CD20 lymphocyte subsets are a good additional marker of autoimmunological processes in DM.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 33 条
[1]   T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes [J].
Almawi, WY ;
Tamim, H ;
Azar, ST .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) :1497-1502
[2]   INSULIN-DEPENDENT DIABETES-MELLITUS AS AN AUTOIMMUNE-DISEASE [J].
BACH, JF .
ENDOCRINE REVIEWS, 1994, 15 (04) :516-542
[3]   Are there unique autoantigens triggering autoimmune diseases? [J].
Bach, JF ;
Koutouzov, S ;
van Endert, PM .
IMMUNOLOGICAL REVIEWS, 1998, 164 :139-155
[4]  
BOTAZZO GF, 1985, NEW ENGL J MED, V313, P353
[5]   ABNORMAL LYMPHOCYTE-T SUBSETS IN TYPE-I DIABETES [J].
FAUSTMAN, D ;
EISENBARTH, G ;
DALEY, J ;
BREITMEYER, J .
DIABETES, 1989, 38 (11) :1462-1468
[6]   Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing [J].
Gessl, A ;
Waldhäusl, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (06) :2204-2209
[7]   Fetal type lymphocytes in insulin dependent diabetes mellitus [J].
Gyarmati, J ;
Szekeres-Barthó, J ;
Fischer, B ;
Soltész, G .
AUTOIMMUNITY, 1999, 30 (02) :63-69
[8]   ABERRANT ACTIVATION OF CD8(+) T-CELL AND CD8(+) T-CELL SUBSETS IN PATIENTS WITH NEWLY-DIAGNOSED IDDM [J].
HEHMKE, B ;
MICHAELIS, D ;
GENS, E ;
LAUBE, F ;
KOHNERT, KD .
DIABETES, 1995, 44 (12) :1414-1419
[9]  
ILONEN J, 1991, CLIN EXP IMMUNOL, V85, P278
[10]   Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus [J].
Knip, M .
ANNALS OF MEDICINE, 1997, 29 (05) :447-451